Marinus Pharmaceuticals drug Ztalmy is now FDA approved for treating the seizures in patients who have CDKL5 deficiency, an inherited form of epilepsy. The drug is the first approved treatment for the rare disorder and it's also Marinus's first approved product.
Additive manufacturing, or 3D printing, has steadily become more mainstream in the medical device sector because of its ability to enable cost-effective, patient-centered device development, particularly in the fields of orthopedic, spine, maxillofacial, and pediatric surgery.
This webinar on April 6th will have perspectives from healthcare, the medical device sector, and the FDA to discuss how each are using 3D printing, the applications they are leveraging it for, how they can produce devices such as surgical tools more economically, the regulatory challenges they face, and how they can collaborate more effectively.
By Toronto Stock Exchange Tuesday, March 22, 2022 7:25 AM
TSX Venture Exchange has a strong history of helping early stage health and life sciences companies raise patient capital for research and development purposes.
A retrospective study published in American Journal of Health-System Pharmacy found that machine learning and advanced analytics technology not only identifies drug diversion – when drugs are stolen from hospitals – but also that the tech can do so 160 days faster than standard methods, and with a 96.3% accuracy rate.
Among the technologies represented by the group are medtech sensors tracking blood pressure, ostomy patient complications, tremor progression in Parkinson's disease patients, balance, cerebrospinal fluid levels, and more.
With analytics, faster, more informed decision-making is possible. This provides opportunities for healthcare leaders and organizations to find greater alignment on priorities, resources and outcomes.
By Michael Schroeder Monday, March 21, 2022 6:12 PM
TimeDoc plans to hire about 350 additional employees in 2022, according to CEO Will Boeglin. That includes additional care coordination staff, sales and marketing personnel and tech developers.
By Ivana Naeymi-Rad Monday, March 21, 2022 5:01 PM
When the healthcare industry talks about data, the conversation usually focuses on interoperability and data standards. While these are certainly important, the most effective way to connect the dots and gain a complete view of a patient is through data normalization.
DNA sequencing power house Illumina sued liquid biopsy company Guardant Health, whose founders used to work for Illumina, claiming the two stole information from Illumina to file patents for Guardant. Illumina alleges that one of the executives misappropriated confidential information while he was still on Illumina's payroll.
Many patients are discharged from the hospital only to be readmitted soon afterward. But recovery coaching programs bolstered by augmented intelligence can significantly reduce readmission rates, improve a patient's overall health and enhance their experience.
No comments